Meghan Oates-Zalesky
GLASGOW, SCOTLAND and CAMBRIDGE, MA, USA, November 10, 2025—At ISPOR Europe 2025 today, MadeAi™, the GenAI-powered evidence synthesis and report generation platform for life sciences, announced the launch of new capabilities designed to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions. With these advancements, MadeAi delivers the most comprehensive, AI-native…
Accuracy and methodological rigor define the credibility of Gen-AI based literature review systems. AI reliability can be assessed through a measurable framework that minimizes hallucinations and ensures scientifically validated outcomes at every stage of evidence synthesis. Download Accuracy in GenAI-Based Literature Review Systems to discover the metrics, methodologies, and best practices shaping the next generation…
Introduction Artificial Intelligence is redefining healthcare and life sciences. From improving patient care to accelerating drug discovery, AI is proving to be more than just a technological trend; it’s a critical enabler of innovation and efficiency. In this article, we explore real-world AI applications in clinical studies, pharmacovigilance, diagnostics, and medical operations. These use cases…
Traditional literature reviews are slow, expensive, and resource-intensive. AI-powered literature reviews streamline evidence synthesis, accelerating timelines while maintaining methodological rigor and transparency. With both self-service and full-service options, AI helps life sciences teams reduce workloads and costs while delivering high-quality results faster. Download Unlock the ROI of GenAI-Enabled Literature Reviews to see how GenAI transforms literature…